Buy Acer Therapeutics Stock | OPXA Stock Price & Latest News | Public
OPXA

Acer Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About OPXA

    Acer Therapeutics, Inc. is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos s...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$30,25M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.25
    1 Year Low$1.08
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app